The Efficacy of Pulse Therapy in Acute Relapse in Multiple Sclerosis Patients:
NCT06280131 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2024-02-28
Summary
This work is aimed to assess the short term effect of pulse therapy on clinical and neurophysiological course before and after pulse therapy in order to understand the possible mechanism of action of steroid therapy on RRMS patients low-dose oral treatment should also be retained for patients in whom this approach seems appropriate
Conditions
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-03-01
- Primary Completion
- 2025-03-01
- Completion
- 2025-04-01
More Related Trials
-
Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)
NCT00001248 ·Status: RECRUITING
-
Effect of Photobiomodulation Treatment in Individuals With Multiple Sclerosis:
NCT03360487 ·Status: UNKNOWN ·Phase: PHASE2
-
Pulse ACTH vs. MP for MS
NCT01049451 ·Status: COMPLETED ·Phase: PHASE1
-
Does Microglial Activation Promote Lesion Growth and Progression Among Multiple Sclerosis Patients
NCT04625049 ·Status: ENROLLING_BY_INVITATION
-
MS-NEUROPLAST: Neuroplasticity of Cortical Areas Induced by Cognitive Training in Patients with Multiple Sclerosis
NCT04806568 ·Status: RECRUITING ·Phase: NA
-
Study of Induction Therapy With Mitoxantrone and Plasmapheresis to Treat Aggressive Multiple Sclerosis
NCT01214317 ·Status: COMPLETED ·Phase: NA
-
Immunological Mechanisms of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis
NCT00342134 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Adrenocorticotropin Injection With Weekly Interferon Beta in Patients With Relapsing Remitting Multiple Sclerosis (MS)
NCT00986960 ·Status: WITHDRAWN ·Phase: PHASE2
-
Assesment of Physical Activity Level of Patients With Multiple Sclerosis: From Laboratory to Real Life
NCT03928990 ·Status: UNKNOWN ·Phase: NA
-
Exercise-based Therapy for Multiple Sclerosis Patients
NCT03735524 ·Status: UNKNOWN ·Phase: NA
-
Prospective Investigation of Multiple Sclerosis in the Three Rivers Region
NCT02994121 ·Status: RECRUITING
-
MRI Biomarkers Predictive of Disability Progression in Patients With Multiple Sclerosis
NCT05491031 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Safety of FTY720 in Patients With Relapsing Multiple Sclerosis
NCT00333138 ·Status: COMPLETED ·Phase: PHASE2
-
Does Long-Term Natalizumab (NTZ) Therapy Normalize Brain Atrophy Rates and Quality of Life (QOL) in Relapsing Remitting Multiple Sclerosis (RRMS)?
NCT02588053 ·Status: COMPLETED
-
Photobiomodulation Therapy in Persons With Multiple Sclerosis
NCT03691766 ·Status: COMPLETED ·Phase: NA
-
Stem Cells in Rapidly Evolving Active Multiple Sclerosis
NCT01606215 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Observational Study in Multiple Sclerosis Patients Treated With Autologous Hematopoietic Stem Cell Transplantation
NCT04674280 ·Status: UNKNOWN
-
Motor Learning of Fall Resistant Skills Through Slip and Trip Exposure in Multiple Sclerosis
NCT06919900 ·Status: RECRUITING ·Phase: NA
-
Cerebrovascular Changes in Multiple Sclerosis Patients
NCT03709290 ·Status: UNKNOWN
-
Exercise Therapy in Multiple Sclerosis
NCT04294979 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Cyclophosphamide Versus Methylprednisolone in Patients With Secondary Progressive Multiple Sclerosis
NCT00241254 ·Status: COMPLETED ·Phase: PHASE3
-
Progression of Cognitive and Physical Symptoms in Multiple Sclerosis
NCT00922831 ·Status: WITHDRAWN
-
An Extension Study of Ublituximab in Participants With Relapsing Multiple Sclerosis
NCT04130997 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Definition of Autonomic Nervous System Involvement in Patients With Multiple Sclerosis
NCT05748015 ·Status: RECRUITING ·Phase: NA
-
Role of Microglia in the Pathogenesis of Progressive Multiple Sclerosis
NCT03134716 ·Status: ACTIVE_NOT_RECRUITING